Back

Multi-Ancestry Survival GWAS of Substance Use Initiation in the ABCD Study

Wei, M.; Peng, Q.

2026-04-11 genetic and genomic medicine
10.64898/2026.04.08.26350431 medRxiv
Show abstract

BackgroundSubstance use initiation in adolescence is influenced by both genetic and environmental factors; however, large-scale genetic studies often treat initiation as a binary outcome and underuse longitudinal timing information. MethodsWe conducted time-to-event (survival) genome-wide association analyses (GWAS) of initiation for four outcomes--alcohol, nicotine, cannabis, and any substance use--using longitudinal follow-up data from the Adolescent Brain Cognitive Development (ABCD) Study. We performed ancestry-stratified GWAS within European (EUR), African (AFR), and Hispanic (HISP) groups, applying consistent quality control and covariate adjustment. Summary statistics were harmonized across ancestries and meta-analyzed using inverse-variance weighted fixed-effects and DerSimonian-Laird random-effects models. We evaluated genomic inflation and heterogeneity (Cochrans Q and I2), identified independent lead variants at genome-wide and suggestive significance thresholds, and assessed cross-trait overlap of associated loci. ResultsIn the multi-ancestry meta-analysis, we observed suggestive association signals across traits (minimum p-values: alcohol [~] 1 x 10-7, any [~] 1 x 10-7, cannabis [~] 5 x 10-8, nicotine [~] 1 x 10-8). Nicotine initiation showed one genome-wide significant variant in both fixed- and random-effects meta-analyses (p < 5 x 10-8). Across traits, suggestive loci demonstrated limited overlap, with the strongest concordance between alcohol and any substance use, consistent with shared liability. Heterogeneity statistics indicated that some loci exhibited cross-ancestry variation in effect estimates. ConclusionsSurvival GWAS leveraging initiation timing can identify genetic signals that may be missed by binary designs and enables principled multi-ancestry synthesis. Our results highlight both shared and trait-specific genetic contributions to early substance initiation and provide a foundation for downstream functional annotation and integrative modeling with environmental risk factors. These findings demonstrate the value of incorporating developmental timing into genetic discovery and provide a framework for integrating longitudinal risk modeling with genomic analyses.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Developmental Cognitive Neuroscience
81 papers in training set
Top 0.1%
27.6%
2
JAMA Network Open
127 papers in training set
Top 0.3%
8.2%
3
Neuropsychopharmacology
134 papers in training set
Top 0.4%
7.1%
4
Drug and Alcohol Dependence
37 papers in training set
Top 0.2%
6.3%
5
Journal of Child Psychology and Psychiatry
25 papers in training set
Top 0.1%
3.6%
50% of probability mass above
6
Nature Human Behaviour
85 papers in training set
Top 0.9%
3.6%
7
Alcohol, Clinical and Experimental Research
12 papers in training set
Top 0.1%
3.1%
8
Nature Communications
4913 papers in training set
Top 43%
2.9%
9
Biological Psychiatry
119 papers in training set
Top 1%
2.6%
10
Molecular Psychiatry
242 papers in training set
Top 1%
2.4%
11
Translational Psychiatry
219 papers in training set
Top 2%
1.9%
12
BMC Medicine
163 papers in training set
Top 3%
1.9%
13
Addiction Biology
47 papers in training set
Top 0.5%
1.7%
14
The British Journal of Psychiatry
21 papers in training set
Top 0.5%
1.7%
15
Behavior Genetics
15 papers in training set
Top 0.1%
1.7%
16
Psychological Medicine
74 papers in training set
Top 1%
1.5%
17
Addiction
25 papers in training set
Top 0.3%
1.5%
18
Biology of Sex Differences
29 papers in training set
Top 0.4%
1.2%
19
Genome Medicine
154 papers in training set
Top 6%
0.9%
20
PLOS ONE
4510 papers in training set
Top 63%
0.9%
21
Nicotine and Tobacco Research
13 papers in training set
Top 0.2%
0.9%
22
Environmental Health Perspectives
17 papers in training set
Top 0.4%
0.9%
23
American Journal of Psychiatry
20 papers in training set
Top 0.4%
0.8%
24
European Neuropsychopharmacology
15 papers in training set
Top 0.5%
0.8%
25
JAMA Psychiatry
13 papers in training set
Top 0.6%
0.7%
26
International Journal of Epidemiology
74 papers in training set
Top 3%
0.6%